文献速递青光眼眼底病与葡萄膜炎

新加坡多族裔人群青光眼风险基因与视网膜神经纤维层厚度的关联

Association of Glaucoma Risk Genes with Retinal Nerve Fiber Layer in a Multi-ethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2020-01-01

该研究基于新加坡眼科疾病流行病学研究(SEED)的3843名参与者(7020只健康眼),分析35个青光眼相关遗传位点与视盘周围视网膜神经纤维层(RNFL)厚度的关联。荟萃分析显示,仅SIX6 rs33912345与整体RNFL变薄显著相关,且在各族裔中一致。

要点

  • SIX6 rs33912345每增加一个风险等位基因,整体RNFL厚度减少1.116 µm(P=1.64E-05)。
  • SIX6对下方RNFL象限效应更大(β=-2.015 µm,P=2.9E-6),上方次之(β=-1.646 µm,P=6.54E-5)。
  • 调整视盘面积及其他视盘参数相关SNP后,SIX6与RNFL厚度的关联仍相似。

核心结论

  • 在35个青光眼风险位点中,仅SIX6与RNFL变薄显著且独立相关,支持SIX6参与RNFL厚度及青光眼发病机制。

研究设计与样本

  • 基于新加坡眼科疾病流行病学研究(SEED)的人群横断面研究,纳入3843名马来、印度、中国族裔参与者的7020只健康眼。
  • 采用谱域光学相干断层扫描(SD-OCT)测量视盘周围RNFL厚度,选取35个独立青光眼相关遗传位点,以加性遗传模型进行线性回归,分族裔分析后荟萃分析。

主要发现

  • 参与者平均年龄59.4±8.9岁,平均RNFL厚度92.3±11.2 µm。
  • 荟萃分析中,仅SIX6 rs33912345与整体RNFL变薄显著相关(β=-1.116 µm/风险等位基因,P=1.64E-05),下方象限β=-2.015 µm(P=2.9E-6),上方象限β=-1.646 µm(P=6.54E-5)。
  • SIX6关联在马来、印度、中国三个族裔中均一致观察到。
  • 其他遗传变异与垂直杯盘比(ATOH7、CDKN2B-AS1、TGFBR3-CDC7)、盘沿面积(SIX6、CDKN2B-AS1)和视盘面积(SIX6、ATOH7、TGFBR3-CDC7)相关。
  • 进一步调整视盘面积及ATOH7、CDKN2B-AS1、TGFBR3-CDC7三个视盘参数相关SNP后,SIX6 rs33912345与RNFL厚度的关联保持相似。

关键数值与推荐

  • SIX6 rs33912345与整体RNFL厚度:β=-1.116 µm/风险等位基因,P=1.64E-05。
  • SIX6 rs33912345与下方RNFL象限:β=-2.015 µm,P=2.9E-6;与上方RNFL象限:β=-1.646 µm,P=6.54E-5。

临床怎么用

  • SIX6 rs33912345可作为与RNFL变薄相关的遗传标记,尤其关注下方和上方RNFL象限的改变。
  • 在青光眼风险评估中,SIX6基因型可能有助于解释RNFL厚度的个体差异,但需结合视盘参数综合判断。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Genome-wide association studies have identified several genes associated with glaucoma. However, their roles in the pathogenesis of glaucoma remain unclear, particularly their effects on retinal nerve fiber layer (RNFL) thickness. The aim of this study was to investigate the associations between the identified glaucoma risk genes and RNFL thickness. METHODS: A total of 3843 participants (7,020 healthy eyes) were enrolled from the Singapore Epidemiology of Eye Diseases (SEED) study, a population-based study composing of three major ethnic groups-Malay, Indian, and Chinese-in Singapore. Ocular examinations were performed, and spectral-domain optical coherence tomography (SD-OCT) was used to measure circumpapillary RNFL thickness. We selected 35 independent glaucoma-associated genetic loci for analysis. An linear regression model was conducted to determine the association of these variants with circumpapillary RNFL, assuming an additive genetic model. We conducted association analysis in each of the three ethnic groups, followed by a meta-analysis of them. RESULTS: The mean age of the included participants was 59.4 ± 8.9 years, and the mean RFNL thickesss is 92.3 ± 11.2 µm. In the meta-analyses, of the 35 glacuoma loci, we found that only SIX6 was significantly associated with reduction in global RNFL thickness (rs33912345; β = -1.116 um per risk allele, P = 1.64E-05), and the effect size was larger in the inferior RNFL quadrant (β = -2.015 µm, P = 2.9E-6), and superior RNFL quadrant (β = -1.646 µm, P = 6.54E-5). The SIX6 association were consistently observed across all three ethnic groups. Other than RNFL, we also found several genetic varaints associated with vertical cuo-to-disc ratio (ATOH7, CDKN2B-AS1, and TGFBR3-CDC7), rim area (SIX6 and CDKN2B-AS1), and disc area (SIX6, ATOH7, and TGFBR3-CDC7). The association of SIX6 rs33912345 with NRFL thickness remained similar after further adjusting for disc area and 3 other disc parameter associated SNPs (ATOH7, CDKN2B-AS1, and TGFBR3-CDC7). CONCLUSIONS: Of the 35 glaucoma identified risk loci, only SIX6 is significantly and independently associated with thinner RNFL. Our study further supports the involvement of SIX6 with RNFL thickness and pathogensis of glaucoma.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Chai X, Low KY, Tham YC, et al. Association of Glaucoma Risk Genes with Retinal Nerve Fiber Layer in a Multi-ethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study. Invest Ophthalmol Vis Sci. 2020. PMID: 32821913. doi:10.1167/iovs.61.10.37

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。